Long‐term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (the DEPICT‐2 study): 52‐week results from a randomized controlled trial

AIM: To investigate the long‐term efficacy and safety of dapagliflozin as an adjunct to adjustable insulin in adults with type 1 diabetes (T1D) and inadequate glycaemic control. MATERIALS AND METHODS: Dapagliflozin Evaluation in Patients with Inadequately Controlled Type 1 Diabetes (DEPICT‐2) was a...

Descripción completa

Detalles Bibliográficos
Autores principales: Mathieu, Chantal, Rudofsky, Gottfried, Phillip, Moshe, Araki, Eiichi, Lind, Marcus, Arya, Niki, Thorén, Fredrik, Scheerer, Markus F., Iqbal, Nayyar, Dandona, Paresh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496089/
https://www.ncbi.nlm.nih.gov/pubmed/32311204
http://dx.doi.org/10.1111/dom.14060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496089/
https://www.ncbi.nlm.nih.gov/pubmed/32311204
http://dx.doi.org/10.1111/dom.14060

Ejemplares similares